Accidental mixed prescription drug toxicity (tramadol, amitriptyline, codeine, diazepam, alprazolam) complicating emphysema with active respiratory bronchiolitis
AI-generated summary
Michelle Jayne Stocks, aged 46, died from accidental mixed prescription drug toxicity in December 2018. She had complex medical conditions including emphysema, fibromyalgia, and chronic pain, managed by her GP Dr Q. returning from Queensland, Dr Q resumed multiple sedating medications (tramadol, amitriptyline, codeine, diazepam, alprazolam) based on a handwritten list she presented, without verifying prescribing in Queensland or conducting adequate risk assessment. Post-mortem revealed fatal tramadol and toxic levels of other CNS depressants. The coroner found Dr Q failed to undertake sufficient risk-benefit assessment, did not verify Queensland prescriptions, and over-relied on pharmacy approval rather than conducting thorough clinical due diligence. Ms Stocks' practice of hoarding medications and taking them irregularly contributed to toxicity. The coroner recommended more careful prescribing practices for complex polypharmacy regimens.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes. Report an inaccuracy.
centrilobular emphysemafibromyalgiaclassical migraineschronic painloin pain haematuria syndromelower back painoesophageal dysmotilityoveractive bladder syndromeopioid toxicitymixed drug toxicityrespiratory depression
Contributing factors
Inadequate risk-benefit assessment of high-risk polypharmacy regimen
Failure to verify prescriptions from Queensland treating doctors
Reliance on unverified handwritten medication list from patient
Over-reliance on pharmacy approval without adequate clinical due diligence
Lack of specialist consultation for complex pain management
Patient's practice of hoarding medications
Patient's inconsistent medication adherence
Patient's underlying lung disease increasing vulnerability to CNS depression
Alcohol consumption combined with CNS depressants
Coroner's recommendations
Dr Q should have conducted a more thorough risk-benefit assessment of the high-risk polypharmacy regimen before issuing prescriptions
Dr Q should have independently verified prescriptions from Queensland treating doctors rather than relying on a handwritten list presented by the patient
Dr Q should have contacted Queensland's Drugs of Dependence Unit to confirm details of any Schedule 8 medicine supplies
Pharmacy approval should not be treated as a substitute for adequate clinical due diligence by the prescribing doctor
Specialist consultation should have been sought for complex pain management cases
Staged supply of medications should have been considered for high-risk regimens
Greater caution should be exercised when treating patients after significant gaps in care or when resuming complex medication regimens without independent verification
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. Some material may have been redacted or restricted by court order or privacy requirements. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction — report an inaccuracy here.